share_log

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma公布了SPC-15的临床前研究结果,强调了将SPC-15与NMDAR拮抗剂结合使用的拟议疗效。
Benzinga ·  11/18 08:42

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma宣布了关于SPC-15的临床前研究结果,强调将SPC-15与NMDAR拮抗剂结合的预期疗效。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发